We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Bio Ascend. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this live activity for a maximum of 9.75 AMA PRA Category 1 CreditsTM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As a jointly accredited provided, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing and commercial bias. All faculty, planners, and others in a position to control continuing education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, and re-selling, or financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
The activity may include presentation in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC or Bio Ascend.
The accredited provided has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of the content prior to assuming their roles:
LEAD 2026 Faculty Financial Disclosures
Faculty / Advisory Committee Member
Financial Relationships
Latifat Akintade, MD
No relevant financial relationships to disclose
Nilofer Azad, MD
No relevant financial relationships to disclose
Maria Quintos Baggstrom, MD, FACP, FASCO
Site PI for Clinical Trial: Black Diamond, Alliance/ECOG, Mythic Therapeutics, Nuvalent
Jodi Bass
No relevant financial relationships to disclose
Carolina Bernabe, MD
No relevant financial relationships to disclose
Julie Brahmer, MD, MSc, FASCO
Consultant: Amgen, AstraZeneca, GlaxoSmithKline, RAPT Therapeutics, Sanofi
Amy Clark, MD
TBC
Meryl Colton, MD
Advisor: Genmab, Pfizer
Madison Conces, MD
Speaker: Incyte Corporation
Advisory Board: Guardant, Johnson & Johnson
Neelima Denduluri, MD, FASCO
Employee: AstraZeneca
Jaydira Del Rivero, MD
No relevant financial relationships to disclose
Nazli Dizman, MD
Ownership/Stock (Significant Other): Medline Global LLC
Consultant: Eisai
Catherine Fahey, MD, PhD
Advisory Board: Exelixis, Johnson & Johnson
Speaker: ASCO, Medical Education Consortium
Idalid Franco, MD, MPH
No relevant financial relationships to disclose
Christine Garcia, MD
Consultant: Catalyst, Janssen, Pfizer, Regeneron, Rigel
Johanna Ghayad, PharmD, ACC
No relevant financial relationships to disclose
Jennifer Grandis, MD
No relevant financial relationships to disclose
Tricia Kalwar, MD, MPH, FASCO
Consultant: Cardinal Health Program, Decera Clinical Education
Catherine Lai, MD, MPH
Consultant: Genentech, Kura
Ad Board: Daiichi Sankyo, Geron, Foundation Oncology, Syndax
Consultant / Ad Board: AbbVie, Astellas, Bristol Myers Squibb, Rigel
Kaitlyn Lapen, MD
No relevant financial relationships to disclose
Yuxin Liu, MD
Research funding: Bristol Myers Squibb, Sanofi
Advisory Board: Opna Bio
Ariella Marshall, MD
No relevant financial relationships to disclose
Kriti Mittal, MD, MS
Education Grant to Institution: Pfizer Honorarium: AstraZeneca, Janssen
Amanda Nizam, MD
No relevant financial relationships to disclose
Coral Olazagasti, MD
TBC
Sapna Patel, MD
TBC
Bhumika Patel, MD
TBC
Elizabeth Plimack, MD, MS, FASCO
Scientific Advisory / Consultant: Astellas, Bristol Myers Squibb, Eisai, Flatiron, Merck
Brittany Ragon, MD
Advisory Board: Astellas, Bristol Myers Squibb, Syndax
Protocol Review: NMDP
Ilana Schlam, MD, MPH
Consultant/Advisor: AstraZeneca, Novartis
Travel Support: Case45
Lynn Schuchter, MD
No relevant financial relationships to disclose
Susan Scott, MD
Research funding (direct to institution),
Consultant: AstraZeneca, Johnson & Johnson
Research funding (direct to institution): Black Diamond Therapeutics, Nuvalent
Consultant: Boehringer Ingelheim, Daiichi Sankyo
Danielle Shafer, DO
TBC
Rachna Shroff, MD, MS, FASCO
Consultant: AstraZeneca, Boston Scientific, Elevar, Foundation Medicine, Genentech, ICON Clinical Research, Syneos
Advisory Board: AstraZeneca, Boehringer-Ingelheim, Exelixis, Jazz, Merck, Novocure, Servier, Zymeworks
Research to Institution: Actuate, Bristol Myers Squibb, Compass, Exelixis, Faeth, Immuno Vaccine, Lisata, Merck, Seagen
Aditi Singh, MD
Institutional Research Funding: Gilead Sciences, Jazz Pharmaceuticals
Harpreet Singh, MD
No relevant financial relationships to disclose
Deborah Stephens, DO
Consultant: AbbVie, AstraZeneca, BeOne, Genentech, Lilly, Johnson & Johnson, Pfizer, Pharmacyclics
Research Funding to Institution: AbbVie, BeOne, Genentech
Katherine Van Loon, MD, MPH
Research Funding: Natera, Pfizer
Ana Velazquez Manana, MD, MSc
Consultant: AstraZeneca, BMS, Boehringer Ingelheim, DSI, EMD Serono, Janssen, Lilly, Nuvation Bio, Pfizer, Regeneron
Claire Verschraegen, MD
Steering Committee Member for Unloxcyt: SunPharma
Latifat Akintade, MD
No financial relationships to disclose
Julie Brahmer, MD, MS
Consultant: Amgen, AstraZeneca, GSK, RAPT Therapeutics, Sanofi Aventis
Pelin Cinar, MD, MS
Employer: Gilead Sciences
Arpita Desai, MD
Advisory Board: Aveo, Exelixis, Janssen, Merck
Nazli Dizman, MD
Stock/Ownership (Significant other): Medline Global Inc.
Consultant: Eisai
Natalie Ertz-Archambault, MD
No financial relationships to disclose
Jacquelyne Gaddy, MD, MSc, MSCR
No financial relationships to disclose
Joanna Ghayad, PharmD, ACC
Employee: Bristol Myers Squibb
Jennifer Grandis, MD
No financial relationships to disclose
Carmen Guerra, MD, MSCE
Member, Advisory Board: Guardant Health, Natera, Roche
Grant (Institution): Genentech
Jennifer Hatcher, RN, PhD
No financial relationships to disclose
Leora Horn, MD, MSc, MHPE, FRCPC
Employee: AstraZeneca
Dame Idossa, MD
Travel: Optum Health, Bio Ascend
Consulting: Trial Library
Shivani Kapur, MD
No financial relationships to disclose
Catherine Lai, MD
Advisor: Daiichi Sankyo, Novartis, Pfizer, Taiho Oncology
Consultant/Ad Board: AbbVie, Astellas, BMS, Rigel
Ad Board: Arcellx, Servier, Syndax
Honoraria: Bio Ascend
Consultant: Genentech, Jazz Pharma, PDS Biotechnology
Deepu Madduri, MD
Employee: Johnson & Johnson
Reshma Mahtani, MD
Consultant: Agendia, Daiichi Sankyo, Eisai, Genentech, Hologic, Lilly, Merck, Novartis, Pfizer, Puma Biotechnology, Sanofi, Stemline, Sermonix Pharmaceuticals
Ariela Marshall, MD
No financial relationships to disclose
Rana McKay, MD
Consultant: Ambrx, Arcus, AstraZeneca, Aveo, Bayer, Blue Earth Diagnostics, Bristol-Myers Squibb, Calithera, Caris, Daiichi Sankyo, Dendreon, Exelixis, Johnson & Johnson, Lilly, Merck, Myovant, Neomorph, Novartis, Pfizer, Sanofi, SeaGen, Sorrento Therapeutics, Telix, Tempus
Neha Mehta-Shah, MD
Advisory Board/Consultant: Acrotech Biopharma, AstraZeneca, C4 Therapeutics, Genentech/Roche, Johnson & Johnson/Janssen, Ono Pharmaceuticals, Pfizer, Secura Bio/Red Nucleus, Verastem
Grant/Institutional Research Funding: AstraZeneca, Bristol Myers Squibb, C4 Therapeutics, Celgene, Corvus Pharmaceuticals, Daiichi Sankyo, Dizal Pharmaceuticals, Genentech/Roche, Innate Pharmaceuticals, MorphoSys, Seagen
Christiana Mo, MD
No financial relationships to disclose
Amanda Nizam, MD
Consulting or advisory role: AVEO Oncology*, Astellas Pharma, Seagen, Pfizer, EMD
Serono/Merck KGaA, Formedics (formerly Mashup Media), IDEOlogy Health*, Medscape
Honoraria: Cleveland Clinic*, Aptitude Health*, Targeted Oncology*, IntegrityCE*, MECC
Global Meetings, ASCO, Doximity*, Flatiron Health, SignifyMD
Bladder Cancer Section Editor: GU Oncology Now
Travel and accommodation expenses: ASCO, MECC Global Meetings, Formedics (formerly Mashup Media)
*Financial relationship ended
Coral Olazagasti, MD
Ad Board: BMS, Pfizer
Consultant: Lung Cancer Today
Sapna Patel, MD
No financial relationships to disclose
Shruti Patel, MD
No financial relationships to disclose
Elizabeth Plimack, MD, MS
Scientific Advisory: AbbVie, AstraZeneca, BMS Eisai, EMD Serono, Flatiron, Astellas, Merck, Pfizer, SeaGen, Signatera, Synthekine, Aura Biosciences, Adaptimmune, 23andMe, Daiichi Sankyo
Gladys Rodriguez, MD
Stock ownership: Abbott Pharmaceuticals, Merck Pharmaceuticals, Novodisk
Lynn Schuchter, MD
No financial relationships to disclose
Lacey Scott Williams, MD
Consultant: Aptitude Health
Rachna Shroff, MD, MS, FASCO
Advisory Board: AstraZeneca, Boehringer Ingelheim Pharmaceuticals., Clovis, Genentech, Natera, Incyte, Merck, QED Therapeutics, Server, Zymeworks Biopharm., Astellas, Duo
Research Funding: IMV Inc., LOXO, Merck, Novocure, NUCANA, Bristol-Myers Squib, Pieris, QED Therapeutics, Seagen, Taiho, Bayer
Consulting: SYROS, Hookipa Pharma, AbbVie, Ability, Elevar Therapeutics
Surbhi Singhal, MD
Consultant: BMS, Caris Life Sciences, Oncohost
Chetasi Talati, MD
Employer: AbbVie
Eleonora Teplinsky, MD
Medical Advisory Board: Sermo
Consultant: AbbVie, AstraZeneca, Daiichi Sankyo, Immunogen, Novartis, Pfizer
Mazie Tsang, MD, MAS, MS
Advisory Board: AstraZeneca, Novartis, TerSera
Stock Ownership: Poseida Therapeutics
Research, Consultancy (to institution): ONO PHARMA, Eli Lilly, Genentech
Chaitra Ujjani, MD
Consultant: AbbVie, ADC Therapeutics, Alara, AstraZeneca, BeiGene, Genmab
Research: AbbVie, AstraZeneca, Lilly Pharmacyclics
Katherine Van Loon, MD, MPH
No financial relationships to disclose
Ana Velazquez Manana, MD
Consultant: AstraZeneca, BMS, Janssen, Merus, Regeneron
To obtain our CME certificate, please click the Claim CME button located at the bottom of this page
We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.